🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the tolerance of intravenous milrinone...
Status
Completed
Location
CHU Nantes
Start Date
2020-08-31
Trial ID
NCT03517670
The purpose of this observational study is to compare the administration of...
Status
Completed
Location
UZ Leuven Gasthuisberg
Start Date
2017-06-30
Trial ID
NCT03250845
This is a study to evaluate the maximum tolerated dose (MTD), occurrence of...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2020-10-12
Trial ID
NCT04412577
Treatments Being Tested
Physical activity levels of adult hematologic cancer patients are deficient...
Status
Completed
Location
Acibadem University
Start Date
2021-02-08
Trial ID
NCT04755465
Treatments Being Tested
For patients who met the inclusion criteria, treatment regimens were admini...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-11-01
Trial ID
NCT07270835
Treatments Being Tested
The purpose of the study is to determine the recommended dose of durvalumab...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-03-07
Trial ID
NCT03837899
Treatments Being Tested
This study is a phase II of effcicacy and tolerance of azacitidine in patie...
Status
Completed
Location
CHU Amiens
Start Date
2017-01-26
Trial ID
NCT02985190
Treatments Being Tested
For several decades, allogeneic hematopoietic stem cell trans-plantation (a...
Status
Recruiting
Location
Chu de Nantes
Start Date
2020-02-09
Trial ID
NCT04180059
Treatments Being Tested
This is an open-label, single arm phase 1 study to evaluate the dose-limiti...
Status
Terminated
Location
Princess Margaret Hospital
Start Date
2009-08
Trial ID
NCT00963495
Treatments Being Tested